Trial Profile
ALEX-XL: Alfuzosin XL-Lower Urinary Tract Symptoms Efficacy and Sexuality Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Mar 2010
Price :
$35
*
At a glance
- Drugs Alfuzosin (Primary)
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Therapeutic Use
- Acronyms ALEX-XL
- Sponsors Sanofi
- 14 Jan 2008 New trial record.